NCT/Study#
NCT04661137 /
KARYOPHARM-IST-318-2020-0369
A Phase 2B Study Of Selinexor (KPT-330), In Combination With Carfilzomib, Daratumumab Or Pomalidomide In Patients With Multiple Myeloma Relapsing On Current Therapy
DISEASE GROUP:
Multiple Myeloma
current phase:
Phase II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
